What progress has FDA made with its FY18 priorities?

Eight months into FDA’s FY2018, let’s look at the progress they have made in achieving their guidance document issuance goals. CDRH published the guidance document prioritization list it intends to work from in FY18 here.

Three lists were provided:
1. A list of guidance documents that the Agency fully intends to publish (the "A-list");
2. A list of guidance documents that the Agency intends to publish as resources permit (the "B-list"); and
3. A list of final guidance documents that issued in 2008, 1998, 1988, and 1978 subject to focused retrospective review.




Should you have any questions, feel free to contact us.

Lorry Weaver Huffman, US Regulatory Affairs Expert


Please follow us on LinkedIn and subscribe to our newsletter to stay up-to-date on the latest regulatory and clinical news in the medical devices area.

Expert profile:
Lorry Weaver
Post date: June 27, 2018
How can we help you? Contact us